Shielding type | n | Mean dose ± SD | ||
---|---|---|---|---|
μSv/procedure | nSv/MBq | |||
None | 9 | 3.4 ± 1.7 | 9.7 ± 2.3 | |
Primary | 9 | 3.6 ± 1.5 | 8.6 ± 2.9 | |
Primary and secondary | 69 | 1.9 ± 0.9 | 4.5 ± 2.2 |
Dose includes period of dose transport and injection. Primary and secondary shielding refers to total of 32.7 mm of lead-equivalent shielding.